| Name | 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide |
|---|---|
| Synonyms |
2-Amino-N-(2-chloro-6-methylphenyl)thiazol-5-cboxamide
2-Amino-5-[(2-chloro-6-methylphenyl)cbamoyl]-1,3-thiazole, 2-Amino-5-[(6-chloro-o-tolyl)cbamoyl]-1,3-thiazole Dasatinib Impurity L T5N CSJ BZ DVMR BG F1 2-Amino-N - (2-chloro-6-methylphenyl) thiazole-5-formamide 2-Amino-N - (2-chloro-6-methylphenyl) -5-thiazolamide Dasatinib Impurity-A Dasatinib Impurity 65 Dasatinib Impurity 27 2-amino-N-(2-chloro-6-Methylphenyl)-1,3-thiazole-5-cboxaMide Dasatinib Aminothiazole Impurity 2-Amino-Ni-(2-chloro-6-methylphenyl)thiazole-5-cboxamide The dimer impurity 2-Amino-N-(2-chloro-6-Methylphenyl)thiazole-5-cb 2-Amino-N-(2-chloro-6-Methylphenyl)thiazole-5-cboxiMide) 2-amino-N-(2-cliloro-6-metliylplienyl)thiazole-5-carboxamide Dasatinib IMpurity 2 Dasatinib Impurity09 2- Amino-N - (2-chloro-6-methylphenyl) thiazole-5-cboxylamide 2-Amino-N-(2-chloro-6-Methylphenyl)-5-thiazolecboxaMide 2-Amino-N-(2-chloro-6-Meth N-(2-chloro-6-methylphenyl)-2-amino-5-thiazolecarboxamide 2-Amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide Dasatinib Int N-2 2-Amino-N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-cboxamide(Intermediate of Dasatinib) 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-cboxamide EOS-61515 2-aminothiazole-5-carboxylic acid (2-chloro-6-methylphenyl)amide dasatinib interMediate 2-Amino-N-(2-chL 2-AMINO-N-(2-CHLORO-6-METHYLPHENYL) THIAZOLE-5-CARBOXAMIDE 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-cboxamide > 5-ThiazolecboxaMide,2-amino-N-(2-chloro-6-Methylphenyl) |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 362.0±37.0 °C at 760 mmHg |
| Melting Point | 210 °C |
| Molecular Formula | C11H10ClN3OS |
| Molecular Weight | 267.735 |
| Flash Point | 172.7±26.5 °C |
| Exact Mass | 267.023315 |
| PSA | 96.25000 |
| LogP | 1.75 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.714 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2934100090 |
|
~92%
302964-24-5 |
| Literature: WO2008/76883 A2, ; Page/Page column 53-54 ; WO 2008/076883 A2 |
|
~92%
302964-24-5 |
| Literature: WO2005/77945 A2, ; Page/Page column 51 ; WO 2005/077945 A2 |
|
~%
302964-24-5 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 13, # 22 p. 4007 - 4010 Bioorganic and Medicinal Chemistry Letters, , vol. 14, # 24 p. 6061 - 6066 |
|
~%
302964-24-5 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 14, # 24 p. 6061 - 6066 |
|
~%
302964-24-5 |
| Literature: Archiv der Pharmazie, , vol. 344, # 7 p. 451 - 458 |
|
~%
302964-24-5 |
| Literature: Archiv der Pharmazie, , vol. 344, # 7 p. 451 - 458 |
| Precursor 3 | |
|---|---|
| DownStream 2 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |